Skip Navigation Links
Centers for Disease Control and Prevention
 CDC Home Search Health Topics A-Z
NIP header
Family
NIP:
bullet NIP HOME
bullet First time visitor?
bullet About NIP
bullet Data and Statistics
bullet International Efforts
bullet Links to other web sites 
bullet Glossary/ Acronyms 

NIP sub-sites:
bullet ACIP
bullet Flu Vaccine
bullet Immunization Registries
bullet Vaccines for Children Program
bullet CASA (Clinic Assessment Program)
bullet AFIX (Grantee Assessment)
bullet VACMAN
 

NIP Site Search
 
National Immunization Hotline
bullet English
(800)232-2522
bullet Spanish
(800)232-0233
bullet TTY
(800)243-7889

Get Acrobat Reader
Get Adobe Reader
 

Vaccine Safety > Issues of Interest > GBS
Guillain-Barre Syndrome (GBS) and 
Influenza Vaccine
Q&A image

Questions answered on this page:

  1. What is Guillain-Barre Syndrome?
  2. What causes GBS?
  3. How often does GBS occur after influenza vaccination?
  4. Should I receive the influenza vaccine?
  5. If I have had GBS, should I receive influenza vaccine?

Articles on this topic:

Institute of Medicine Report: ...Guillain-Barré Syndrome Linked Only to 1976 Swine Flu Vaccine (released Oct. 6, 2003)


Each year with the beginning of the annual influenza season, there are questions about influenza vaccine, a medical condition known as Guillain-Barre Syndrome (GBS) and their possible association.

  1. What is Guillain-Barre Syndrome?
    GBS is a rare neurological disease characterized by loss of reflexes and temporary paralysis usually beginning in the lower extremities (legs) and moving to the upper extremities (arms).

    The main symptoms of GBS are weakness, numbness, tingling, prickling and increased sensitivity that spreads over the body. Muscle paralysis usually starts in the feet and legs, and can sometimes involve respiratory muscles that help with breathing. The symptoms of GBS usually appear over the course of a single day and may continue to progress for 3 or 4 days up to 3 or 4 weeks. The symptoms in more than 90 percent of the cases reach a peak by 4 weeks. Although fatal in five percent or less of cases, recovery usually begins within 2 to 4 weeks after the progression stops. In some cases recovery may be delayed for months. However, while most patients recover functionally; some persistent symptoms may be present in 15-20% of patients.

Top

  1. What causes GBS?
    The actual cause(s) of GBS are unknown, but the most common predisposing conditions to GBS are bacterial or viral infections, or surgery.

    More than half of all patients with GBS have a history of an acute infectious illness, in the 1 to 4 weeks prior to the onset of neurologic symptoms.

    Recently, Campylobacter, a bacteria commonly found inadequately cooked food, especially poultry, has been implicated as one of the likely causes of GBS. There have been rare reports of GBS after the administration of some vaccines. The 1976 swine influenza vaccine was shown to increase the rate of GBS by slightly less than one case per 100,000 vaccinations. Unlike the 1976 swine influenza vaccine, subsequent vaccines prepared from other virus strains have not been clearly associated with an increased frequency of GBS.

Top

  1. How often does GBS occur after influenza vaccination?
    The vast majority (>99%) of patients with GBS have not recently received a vaccination. Reports of GBS after the administration of vaccines are therefore rare. In most cases where GBS developed after an immunization, proof that the vaccine caused GBS has not been established.

    The risk of developing GBS following immunization is therefore extremely small if at all. Even when there has been a suggestion of a causal association, it is likely to have been no more than 1-2 cases of GBS per million vaccinations. Obtaining a precise estimate of a small increase in risk is difficult for a rare condition such as GBS, which has an annual background incidence of only 1 to 2 cases per 100,000 adult population.

Top

  1. Should I receive the influenza vaccine?
    Yes, if you are 65 years of age or over and are in a high risk group. For other persons, you may wish to seek advice from your health care provider. The estimated risk of GBS, if it exists, is substantially less than that of severe influenza.

Top

  1. If I have had GBS in the past, should I receive influenza vaccine?
    The incidence of GBS in the general population is very low, persons with a history of GBS have a greater chance of developing GBS than persons without such a history. Thus, the likelihood of developing GBS is expected to be greater among persons with a history of GBS than among persons with no history of this syndrome. Whether influenza infection or influenza vaccination might be causally associated with this risk for GBS recurrence is not known. For persons known to have developed GBS within 6 weeks of a previous influenza vaccination, avoiding future influenza vaccinations may be prudent. Other persons with a history of GBS are likely to be at increased risk of complications from influenza disease. The established benefits of influenza vaccination probably justify their receipt of annual influenza vaccinations.

Top

References

Adverse Events Associated with Childhood Vaccines, Institute of Medicine, Evidence Bearing on Causality, Institute of Medicine, 1994, page 37-47.

Epidemiology and Prevention of Vaccine Preventable Diseases, 4th Edition, The Pink Book, Centers for Disease Control, September 1997.

MMWR, Vol. 46/No. RR-9, April 25, 1997, page 8-9.

 

Return to Safety Issues main page

Top of page


National Immunization Program (NIP)
NIP Home | Contact Us | Help | Glossary | About | Accessibility

This page last modified on October 16, 2003

   

Department of Health and Human Services
Centers for Disease Control and Prevention
CDC Home
  |  CDC Search  |  CDC Health Topics A-Z